In the last 15 years, molecular studies have highlighted the role e of genes called “Oncodrivers” involved in tumor genesis, particularly Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK), which have become the target of specific and selective drugs.12 Here, ALK is linked to neoplasm.